Диссертация (1173229), страница 25
Текст из файла (страница 25)
Occurrence of self-reported systemic medical conditions inpatients with periodontal disease // Rom. J. Intern. Med., 2006, Vol. 44(1), P. 35 –48.259. Elkhouli A.M. The efficacy of host response modulation therapy (omega-3plus low-dose aspirin) as an adjunctive treatment of chronic periodontitis (clinicaland biochemical study) // J. Periodont.
Res., 2011, Vol. 46, № 2, P. 261 – 268.260. El-Shinnawi U.M., El-Tantawy S.I. The effect of alendronate sodium on alveolar bone loss in periodontitis (clinical trial) // J. Int. Acad. Periodont., 2003,Vol. 5, P. 5 – 10.261. Emerich K., Melkowski T., Adamowicz–Klepalska B. Dental aspects of ju-141venile idiopathic arthritis (JIA) // Europ.
Arch. Paediat. Dent., 2013, Vol. 14, № 2,р. 119.262. Emingil G., Atilla G., Sorsa T., Luoto H., Kirilmaz L., Baylas H. The effectof adjunctive low-dose doxycycline therapy on clinical parameters and gingivalcrevicular fluid matrix metalloproteinase-8 levels in chronic periodontitis // J.Periodontol., 2004, Vol. 75, Р. 106 – 115.263. Emingil G., Atilla G., Sorsa T., Savolainen P., Baylas H. Effectiveness ofadjunctive low-dose doxycycline therapy on clinical parameters and gingivalcrevicular fluid laminin-5 gamma-2 chain levels in chronic periodontitis // J.Periodontol., 2004, Vol. 75, P. 1387 – 1396.264.
EngebretsonS.P., Hey-HadaviJ.Sub-antimicrobialdoxycyclinefor periodontitis reduces hemoglobin A1c in subjects with type 2 diabetes: a pilotstudy // Pharmacol. Res., 2011, Vol. 64, № 6, P. 624 – 629.265. Espinoza L.R., García-Valladares I. Of bugs and joints: the relationship between infection and joints // Reumatol. Clin., 2013, Vol. 9(4), P. 229 – 238.266. Fernández-Llanio Comella N., Fernández Matilla M., Castellano Cuesta J.A.Have complementary therapies demonstrated effectiveness in rheumatoid arthritis?// Reumatol Clin., 2016, May-Jun, Vol. 12(3), P.
151 – 157.267. Fuggle N.R., Smith T.O., Kaul A., Sofat N. Hand to mouth: A systematicreview and meta-analysis of the association between rheumatoid arthritis and periodontitis // Front Immunol., 2016, Vol. 2;7, p. 80.268. Gapski R., Barr J.L., Sarment D.P. et al. Effect of systemic matrix metalloproteinase inhibition on periodontal wound repair: a proof of concept trial // J.Periodontol., 2004, Vol. 75, Р. 441 – 452.269. García-Magallón B., Silva-Fernández L., Andreu-Sánchez J.L. Update onthe use of steroids in rheumatoid arthritis // Reumatol. Clin., 2013, Vol.
9(5), P.297 – 302.270. Georgiou Т.О., Marshall R.I., Bartold P.M. Prevalence of systemic diseasesin Brisbane general and periodontal practice patients // Aust. Dent. J., 2004, Vol.142№ 49, № 4, P. 177 – 184.271. Goh C.E., Kopp J., Papapanou P.N., Molitor J.A., Demmer R.T. Associationbetween serum antibodies to periodontal bacteria and rheumatoid factor in the thirdnational health and nutrition examination survey // Arthritis Rheumatol., 2016,Vol. 68(10), P. 2384-93.272.
Gokhale S.R., Padhye A.M. Future prospects of systemic host modulatoryagents in periodontal therapy // Br. Dent. J., 2013, Vol. 214, № 9, Р. 467 – 471.273. Golub L.M., McNamara T.F., Ryan M.E., et al. Adjunctive treatment withsubantimicrobial doses of doxycycline: effects on gingival fluid collagenase activity and attachment loss in adult periodontitis // J. Clin. Periodontol., 2001, Vol. 28,Р. 146 – 156.274. Gonzalo-Gil E., Galindo-Izquierdo M. Role of transforming growth factorbeta (TGF) beta in the physiopathology of rheumatoid arthritis // Reumatol. Clin.,2014, Vol.
10(3), P. 174 – 179.275. Gorska R., Nedzi-Gora M. The effects of the initial treatment phase and ofadjunctive low dose doxycycline therapy on clinical parameters and MMP-8,MMP-9, and TIMP-1 levels in the saliva and peripheral blood of patients withchronic periodontitis // Arch. Immunol. Ther. Exp., 2006, Vol. 54, P. 419 – 426.276. Grover H.S., Luthra S., Maroo S. Teriparatide: a novel means to ultimatelyachieve true regeneration ! // J. Clin. Diagn. Res., 2013, Vol. 7, № 8, P. 1820 –1823.277. Grover H.S., Luthra S., Maroo S., Maroo N.
The pleotropic role of statins:Could it be the imminent host modulation agent in periodontics? // Dent. Res. J.(Isfahan), 2013, Vol. 10, № 2, Р. 143 – 148.278. Gupta S., Gupta H., Mandhyan D., Srivastava S. Bisphophonates related osteonecrosis of the jaw // Natl. J. Maxillofac. Surg., 2013, Vol. 4, № 2, P. 151 –158.279.
Gurkan A., Cinarcik S., Huseyinov A. Adjunctive subantimicrobial dosedoxycycline: effect on clinical parameters and gingival crevicular fluid transform-143ing growth factor beta levels in severe, generalized chronic periodontitis // J. Clin.Periodontol., 2005, Vol. 32, P.
244 – 253.280. Haffajee A.D., Torresyap G., Socransky S.S. Clinical changes followingfour different periodontal therapies for the treatment of chronic periodontitis: 1year results // J. Clin. Periodont., 2007, Vol. 34, P. 243 – 253.281. Hajishengallis G. Toll gates to periodontal host modulation and vaccinetherapy // Periodontol. 2000., 2009, Vol. 51, P.
181 – 207.282. Havemose-Poulsen A., Sherensen L.K., Stoltze K., Bendtzen K., HolmstrupP. Cytokine profiles in peripheral blood and whole blood cell cultures associatedwith aggressive periodontitis, juvenile idiopathic arthritis, and rheumatoid arthritis// J. Periodontol., 2005, Vol. 76, № 12, P. 2276 – 2285.283. Havemose-Poulsen A., Serensen L.K., Bendtzen K., Holmstrup P. Polymorphisms within the IL-1 gene cluster: effects on cytokine profiles in peripheralblood and whole blood cell cultures of patients with aggressive periodontitis, juvenile idiopathic arthritis, and rheumatoid arthritis // J.
Periodontol., 2007, Vol. 78,№ 3, P. 475 – 492.284. Havemose-Poulsen A., Westergaard J., Stoltze K. et al. Periodontal and hematological characteristics associated with aggressive periodontitis, juvenile idiopathic arthritis, and rheumatoid arthritis // Periodontol., 2006, Vol. 77, № 2, P.
280– 288.285. Haynes D.R. Bone lysis and inflammation // Inflamm. Res., 2004, Vol. 53,№ 11, P. 596 – 600.286. Heintz C., Mair W. You are what you host: microbiome modulation of theaging process // Cell., 2014, Vol. 156, № 3, P. 408 – 411.287. Hilchie A.L., Wuerth K., Hancock R.E.
Immune modulation by multifacetedcationic host defense (antimicrobial) peptides // Nat. Chem. Biol., 2013, Vol. 9, №12, P. 761 – 768.288. Helenius L.M., Meurman J.H., Helenius I., Kari K. et al. Oral and salivaryparameters in patients with rheumatic diseases // Acta Odontol. Scand., 2005, Vol.14463, № 5, P. 284 – 293.289. Hirsch R., Deng H., Laohachai M.N. Azithromycin in periodontal treatment: more than an antibiotic // J. Periodontal. Res., 2012, Vol.
47, № 2, Р. 137 –148.290. Hogan K.N., Milchak J.L., Heilmann R.M., Billups S.J., Delate T. Evaluation of primary nonadherence to oral bisphosphonate therapy // J. Am. Geriatr.Soc., 2013, Vol. 61, № 11, Р. 2046 – 2047.291. Huang R.Y., Lu S.H., Su K.W. et al. Diacerein: a potential therapeutic drugfor periodontal disease // Med. Hypotheses., 2012, Vol. 79, № 2, Р.
165 – 167.292. Ilgenli T., Vardar-Sengul S., Gurkan A. et al. Gingival crevicular fluid matrix metalloproteinase-13 levels and molecular forms in various types of periodontal diseases // Oral Dis., 2006, Vol. 12, № 6, Р. 573 – 579.293. Jo A.R., Baek K.J., Shin J.E., Choi Y. Mechanisms of IL-8 suppression byTreponema denticola in gingival epithelial cells // Immunol. Cell. Biol., 2014, Vol.92, № 2, P.
139 – 147.294. Kadkhoda Z., Amirzargar A., Esmaili Z., Vojdanian M., Akbari S. Effect ofTNF-α blockade in gingival crevicular fluid on periodontal condition of patientswith rheumatoid arthritis // Iran J. Immunol., 2016, Vol. 13(3), P. 197 – 203.295. Kaipatur N.R., Wu Y., Adeeb S. et al. Impact of bisphosphonate drug burden in alveolar bone during orthodontic tooth movement in a rat model: a pilotstudy // Am. J. Orthod.
Dentofacial Orthop., 2013, Vol. 144, № 4, P. 557 – 567.296. Kaneko C., Kobayashi T., Ito S., Sugita N., Murasawa A., Nakazono K.,Yoshie H. Circulating levels of carbamylated protein and neutrophil extracellulartraps are associated with periodontitis severity in patients with rheumatoid arthritis:A pilot case-control study // PLoS One, 2018, Vol. 2, № 13(2), e0192365.297. Kats A., Båge T., Georgsson P. et al. Inhibition of microsomal prostaglandin E synthase-1 by aminothiazoles decreases prostaglandin E2 synthesis in vitroand ameliorates experimental periodontitis in vivo // FASEB J., 2013, Vol.
27, №6, Р. 2328 – 2341.145298. Kaur K., Sikri P. Evaluation of the effect of allograft with doxycycline versus the allograft alone in the treatment of infrabony defects: A controlled clinicaland radiographical study // Dent. Res. J. (Isfahan), 2013, Vol. 10, № 2, P. 238 –246.299. Kim I., Ki H., Lee W., Kim H., Park J.B. The effect of systemically administered bisphosphonates on bony healing after tooth extraction and osseointegrationof dental implants in the rabbit maxilla // Int. J. Oral. Maxillofac.
Implants., 2013,Vol. 28, № 5, P. 1194 – 1200.300. Kim J.W., Kong K.A., Kim S.J., Choi S.K., Cha I.H., Kim M.R. Prospective biomarker evaluation in patients with osteonecrosis of the jaw who receivedbisphosphonates // Bone, 2013, Vol. 57, № 1, Р. 201 – 205.301. Kriebel K., Hieke C., Müller-Hilke B., Nakata M., Kreikemeyer B. Oral biofilms from symbiotic to pathogenic interactions and associated disease-connectionof periodontitis and rheumatic arthritis by peptidylarginine deiminase // FrontMicrobiol., 2018, Vol. 30, № 9, p.
53.302. Kumar P., Kumar L., Murthy S., Gurudath G. Matrix metalloprotienasesand its inhibitors: an insight // J. Int. Oral. Health., 2014, Vol. 6, № 1, P. 127 –129.303. La V.D., Tanabe S., Bergeron C., Gafner S., Grenier D. Modulation of matrix metalloproteinase and cytokine production by licorice isolates Licoricidin andLicorisoflavan A: potential therapeutic approach for periodontitis // J. Periodontol.,2011, Vol. 82, № 1, Р. 122 – 128.304.
Lam D.K., Sandor G.K., Holmes H.I., Evans A.W., Clokie C.M. A review ofbisphosphonate-associated osteonecrosis of the jaws and its management // J. Can.Dent. Assoc., 2007, Vol. 73, P. 417 – 422.305. Lecomte M., Begot E., Barraud O., Matt M., François B. Routine toothbrushing in the intensive care unit: A potential risk factor for oral flora bacteremiain immunocompromised patients // Med. Intensiva, 2017, Vol. 41(1), P. 53 – 55.306. Le Henaff C., Velard F., Jacquot J.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
